Gw Pharma ADR (GWPH)
$165.46 0.55 (0.33%)
17:34 EDT GWPH Stock Quote Delayed 15 Minutes
Previous Close $0.00
Market Cap 4.67B
PE Ratio -
Volume (Avg. Vol.) 294,000
Day's Range 164.07 - 167.99
52-Week Range 90.14 - 196.00
Dividend & Yield N/A (N/A)
GWPH Stock Predictions, Articles, and Gw Pharma ADR News
- From InvestorPlace
- From the Web
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
There are plenty of marijuana stocks to buy these days. However, these three could be the only ones really worth it for the long haul.
The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.
This week started strong for GW Pharmaceuticals, as management continues to deliver on promises, so GWPH stock should continue to deliver profits.
GW Pharmaceuticals (GWPH) reported its latest quarterly earnings results after hours today, bringing in sales that surged more than 1200%.
With the bull market continuing at a breakneck pace, you want to look for strong buy stocks with plenty of support in case of pullback.
Medical cannabis’ cheap costs and natural uses will benefit GW Pharmaceuticals stock in the long run, keeping GWPH stock growing.
A portfolio should hold high-risk, high-reward plays. And these nine stocks to buy offer big risks and even bigger potential returns.
The ETFMG Alternative Harvest (MJ) ETF enables investors to take advantage of long-term trends in marijuana stocks.
GW Pharmaceutical reported its quarterly earnings results late on Tuesday, bringing in revenue that was thrice the amount it was a year ago.
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
Like most cannabis stocks, GW Pharmaceuticals has become unpredictable, but reading one key chart indicator could help investor profit in GWPH stock.
Looking for stocks to buy before the Santa Claus rally? These 5 'Strong Buy' stocks have the backing of Wall Street's top analysts
GW Pharmaceuticals (GWPH) stock is down more than 5% as the company's fourth-quarter revenue came in below what analysts were projecting.
There was good news for marijuana stocks today after GW Phamaceuticals (GWPH) announced recent results from a late-stage study.
The future of marijuana stocks is a viable concept, as legalization will increase the use of pot and millions more potential users will try it.
Marijuana stocks like Cronos, Cannabis Sativa and Canopy Growth are just a handful of the names worth a closer look here.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!